...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19

I think the key phrase there is "IF we see the positive results in Phase II".  Should those positive results materialize in a significant and demonstrable way then that would be a game changer.  If not then it could set things back for BoM2 more than if this Covid trial had not taken place at all.  So, it's a risk but one they have to take.  

Share
New Message
Please login to post a reply